In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stryker Corporation

https://www.stryker.com/

Latest From Stryker Corporation

Updated: Minute Insight: FDA Clears Zimmer Biomet’s Identity Shoulder, ZB Calls It ‘Biggest Shoulder Launch In the Last Five Years’

Zimmer Biomet said on 20 September that the FDA cleared its Identity shoulder system and expects it to be available to US surgeons in the fourth quarter.  

Minute Insights Orthopedics

Exec Chat: 'Wow Factor' Is Important in Medtech Investment, But It’s Not Everything Says Ceros CEO

Medtech Insight interviewed the CEO of Ceros Financial Services and its investment banking division, Ceros Capital Markets, about the firm’s considerations for funding early-stage medtechs, and outlook for medtech fundraising, in this uncertain economic climate.

Exec Chats Investor Eye

Inflation, Supply Chain Headaches And Staffing Shortages: CEOs Talk About 'Big Picture' Challenges

Although procedure volumes have mostly recovered from the shock of COVID-19 two years ago, the effects of the pandemic on the medtech sector and the economy overall will be felt for years to come. In recent analyst and sales and earnings presentations, CEOs of major medtech companies faced questions about how their company is handling these major "macro" issues.

Leadership Sales & Earnings

Inflation, Supply Chain Headaches And Staffing Shortages: CEOs Talk About 'Big Picture' Challenges

Although procedure volumes have mostly recovered from the shock of COVID-19 two years ago, the effects of the pandemic on the medtech sector and the economy overall will be felt for years to come. In recent analyst and sales and earnings presentations, CEOs of major medtech companies faced questions about how their company is handling these major "macro" issues.

Leadership Sales & Earnings
See All

Company Information

  • Industry
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Digital Health
    • Artificial Intelligence
  • Other Names / Subsidiaries
    • Altitude Group Holdings, Inc.
    • Altitude Merger Sub, Inc.
    • Ascent Healthcare Solutions, Inc.
    • Berchtold Holding Ag
    • CHG Hospital Beds, Inc.
    • Concentric Medical, Inc.
    • Entellus Medical, Inc.
    • Gauss Surgical Inc.
    • Gaymar
    • Howmedica Osteonics
    • GYS Tech, LLC
    • HyperBranch Medical Technology, Inc.
    • Invuity, Inc.
    • Ivy Sports Medicine, LLC.
    • K2M, Inc.
    • K2M Group Holdings, Inc.
    • Mobius Imaging
    • MAKO Surgical Corp.
    • Memometal
    • Muka Metal, A.S.
    • Mobius Imaging, LLC
    • Neurovascular
    • OrthoSpace Ltd.
    • Orthovita Inc.
    • OtisMed Corporation
    • Patient Safety Technologies
    • Physio-Control International, Inc.
    • Pivot Medical
    • Porex
    • SafeWire
    • Sage Products, LLC
    • SightLinep
    • Small Bone Innovations
    • Sonopet
    • SpineCore, Inc.
    • Stanmore Implants Worldwide Limited
    • Surpass Medical LTD
    • Synergetics USA, Inc. (neuro portfolio)
    • Trauson Holdings Company Limited
    • Vexim, Inc.
    • Vocera Communications, Inc.
    • Wright Medical Group N.V.
UsernamePublicRestriction

Register